US20050267547A1 - Microstimulator treatment for sleep apnea or snoring - Google Patents

Microstimulator treatment for sleep apnea or snoring Download PDF

Info

Publication number
US20050267547A1
US20050267547A1 US11/197,054 US19705405A US2005267547A1 US 20050267547 A1 US20050267547 A1 US 20050267547A1 US 19705405 A US19705405 A US 19705405A US 2005267547 A1 US2005267547 A1 US 2005267547A1
Authority
US
United States
Prior art keywords
microstimulator
muscle
anatomical structure
insertion tool
snoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/197,054
Inventor
Mark Knudson
Robert Nickoloff
Timothy Conrad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Xomed LLC
Original Assignee
Restore Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Restore Medical Inc filed Critical Restore Medical Inc
Priority to US11/197,054 priority Critical patent/US20050267547A1/en
Publication of US20050267547A1 publication Critical patent/US20050267547A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula

Definitions

  • This invention is directed to method and apparatus for treating snoring.
  • Snoring has received increased scientific and academic attention.
  • One publication estimates that up to 20% of the adult population snores habitually.
  • Huang, et al. “Biomechanics of Snoring”, Endeavour , Vol. 19, No. 3, pp. 96-100 (1995).
  • Snoring can be a serious cause of marital discord.
  • snoring can present a serious health risk to the snorer.
  • collapse of the airway during sleep can lead to obstructive sleep apnea syndrome. Id.
  • Surgical treatments have been employed.
  • One such treatment is uvulopalatopharyngoplasty.
  • so-called laser ablation is used to remove about 2 cm of the trailing edge of the soft palate thereby reducing the soft palate's ability to flutter between the tongue and the pharyngeal wall of the throat.
  • the procedure is frequently effective to abate snoring but is painful and frequently results in undesirable side effects.
  • removal of the soft palate trailing edge comprises the soft palate's ability to seal off nasal passages during swallowing and speech.
  • fluid escapes from the mouth into the nose while drinking. Huang, et al., supra at 99.
  • Uvulopalatopharyngoplasty is also described in Harries, et al., “The Surgical treatment of snoring”, Journal of Laryngology and Otology , pp. 1105-1106 (1996) which describes removal of up to 1.5 cm of the soft palate. Assessment of snoring treatment is discussed in Cole, et al., “Snoring: A review and a Reassessment”, Journal of Otolaryngology , pp. 303-306 (1995).
  • Huang, et al., supra describe the soft palate and palatal snoring as an oscillating system which responds to airflow over the soft palate. Resulting flutter of the soft palate (rapidly opening and closing air passages) is a dynamic response generating sounds associated with snoring.
  • Huang, et al. propose an alternative to uvulopalatopharyngoplasty. The proposal includes using a surgical laser to create scar tissue on the surface of the soft palate. The scar is to reduce flexibility of the soft palate to reduce palatal flutter.
  • Huang, et al. report initial results of complete or near-complete reduction in snoring and reduced side effects.
  • Surgical procedures such as uvulopalatopharyngoplasty and those proposed by Huang, et al., continue to have problems.
  • the area of surgical treatment i.e., removal of palatal tissue or scarring of palatal tissue
  • Surgical lasers are expensive.
  • the proposed procedures are painful with drawn out and uncomfortable healing periods.
  • the procedures have complications and side effects and variable efficacy (e.g., Huang, et al., report promising results in 75% of patients suggesting a full quarter of patients are not effectively treated after painful surgery).
  • the procedures may involve lasting discomfort. For example, scar tissue on the soft palate may present a continuing irritant to the patient.
  • the procedures are not reversible in the event they happen to induce adverse side effects not justified by the benefits of the surgery.
  • a method and apparatus for treating snoring of a patient.
  • the invention includes implanting a stimulating electrode into a patient.
  • the electrode is placed in stimulating contact with an airway passage-controlling muscle of the patient.
  • the electrode is energized to contract the muscle and alter the airway passage.
  • FIG. 1 is a side sectional view of a portion of a human head showing a soft palate in a relaxed state and in relation in adjacent anatomical features;
  • FIG. 2 is a portion of the view of FIG. 1 showing the soft palate in a flexed state
  • FIG. 3 is a front view of an interior of the mouth shown in FIG. 1 and showing an area to be ablated according to a first prior art surgical procedure;
  • FIG. 4 is the view of FIG. 3 and showing an area to be scarred according to a second prior art surgical procedure
  • FIG. 5 is a schematic representation of a spring-mass system model of the soft palate
  • FIG. 6 is the view of FIG. 1 showing electrodes placed in the muscles of the soft palate, tongue and throat;
  • FIG. 7 is a schematic representation of a pacing electrode inductively coupled to a control device.
  • the hard palate HP overlies the tongue T and forms the roof of the mouth M.
  • the hard palate HP includes a bone support B and does not materially deform during breathing.
  • the soft palate SP is soft and is made up of mucous membrane, fibrous and muscle tissue extending rearward from the hard palate HP.
  • a leading end LE of the soft palate SP is anchored to the trailing end of the hard palate HP.
  • a trailing end TE of the soft palate SP is unattached. Since the soft palate SP is not structurally supported by bone or hard cartilage, the soft palate SP droops down from the plane of the hard palate HP in an arcuate geometry of repose.
  • the pharyngeal airway passes air from the mouth M and the nasal passages N into the trachea TR.
  • the portion of the pharyngeal airway defined between opposing surfaces of the upper surface of the soft palate SP and the wall of the throat is the nasopharynx NP.
  • the soft palate SP is in the relaxed state shown in FIG. 1 with the nasopharynx NP unobstructed and with air free to flow into the trachea TR from both the mouth M and the nostrils N.
  • the soft palate SP flexes and extends (as shown in FIG. 2 ) to close the nasopharynx NP thereby preventing fluid flow from the mouth M to the nasal passages N.
  • the epiglottis EP closes the trachea TR so that food and drink pass only into the esophagus ES and not the trachea TR.
  • the soft palate SP is a valve to prevent regurgitation of food into the nose N.
  • the soft palate SP also regulates airflow through the nose N while talking. Since the soft palate SP performs such important functions, prior art techniques for surgically altering the soft palate SP can compromise these functions.
  • Huang, et al. analogize the shortening of the soft palate SP in uvulopalatopharyngoplasty as effectively raising the critical air flow speed at which soft palate flutter will occur.
  • the shaded area SA in FIG. 3 shows the area of the trailing end TE of the soft palate SP to be removed during this procedure.
  • the alternative procedure proposed by Huang, et al. reduces the flexibility of the soft palate SP through surface scarring which is asserted as effecting the critical flow speed.
  • the shaded area SA′ in FIG. 4 shows the area to be scarred by this alternate procedure.
  • dashed line L shows the demarcation between the soft and hard palates.
  • the present invention is directed to a method and apparatus for altering the dynamic response of the soft palate by altering airflow past the soft palate.
  • the soft palate With reference to the spring-mass model ( FIG. 5 ), the soft palate is moved by airflow. Airflow through an orifice varies in response to the orifice size.
  • the present invention alters the size of the air passage through a minimally invasive surgical implant to allow stimulation of airway defining muscles of the oro-pharynx (i.e., mouth and throat).
  • the present invention stimulates muscles of one or more of the soft palate SP, tongue T and back of the throat.
  • these muscles include, but are not limited to, the Levator veli paltini, the dextera, the Palatopharyngeous and the Palatoglossus muscles.
  • these muscles include, but are not limited to, the Superior, Middle and Inferior pharyngeal constrictor, the Salpingopharyngeous and the Stylopharyngeous muscles.
  • these muscles include, but are not limited to, the Genioglossus and Geniohyoid muscles.
  • Stimulating the muscles of the soft palate, tongue and throat is intended to alter the dynamic response of the soft palate to airflow. Namely, stimulation of the soft palate SP causes the soft palate to move away from the tongue T, stimulation of the tongue T causes the tongue T to move away from the soft palate SP, and stimulation of the back of the throat causes the throat to move rearwardly. Alone or in combination, these actions increase the size of the airway thereby decreasing air velocity and the disrupting force which would otherwise cause oscillation of the soft palate SP.
  • Implantable muscle stimulating electrodes are well known and may be such as those used in cardiac pacing.
  • the implant 10 , 10 ′, 10 ′′ can be positioned and stimulated in a plurality of ways to alter the shape of the airway, to change the dynamic response of the airway tissues or a combination of both.
  • the electrodes 10 , 10 ′, 10 ′′ that will be described are easy to insert in a small incision resulting in reduced patient discomfort and are not exposed to the interior of the mouth (such as the surface scarring of Huang, et al.) as a patient irritant.
  • the degree of dynamic remodeling and stimulation pattern can be fine tuned avoiding the need for excessive anatomical modification and are reversible in the event of adverse consequences.
  • the present invention permits the surgeon to apply stimulation to various muscles until the desired alteration in airway area and tone is achieved so that snoring inducing oscillation is abated at normal airflow.
  • the individual electrodes 10 , 10 ′, 10 ′′ may be placed into the soft palate, tongue or throat muscles through small individual incisions closed by sutures which is much less traumatic than the gross anatomical destruction of uvulopalatopharyngoplasty or the large surface area scarring proposed by Huang, et al.
  • a control device 20 is provided for controlling the electrodes 10 , 10 ′, 10 ′′.
  • the control device 20 is shown as a removable appliance (schematically shown in FIG. 6 with it being appreciated that appliances for placement in the mouth are well known) which fits the form of the hard palate or sub-lingual spaces.
  • the control device 20 is electrically coupled to the electrodes 10 , 10 ′, 10 ′′ through electromagnetic coupling which avoids the need for electrode leads being exposed from the implants 10 , 10 ′, 10 ′′.
  • the electrode 10 (shown in FIG. 7 and it being appreciated that electrodes 10 ′, 10 ′′ are of similar construction) includes a pacing electrode 12 for stimulating muscle in response to a signal through the electrode 10 .
  • Leads 14 connect the pacing electrode 12 to an inductive winding 16 .
  • the entire electrode 10 i.e., each of the components of the pacing electrode 12 , leads 14 and winding 16 ) are imbedded in the patient and not exposed.
  • the control device 20 is shown schematically and includes an inductive winding 22 connected to a control circuit 24 .
  • Control circuit 24 is only shown schematically.
  • Control circuits for pacing electrodes are well known and widely used in cardiac pacing.
  • none of the components of the control device 20 i.e., the winding 22 and circuit 24
  • such components are contained in the removable oral appliance control device 20 although some elements (e.g., a battery may be worn externally by the patient).
  • the control winding 22 is positioned on the control device 20 to be inductively coupled to the electrode winding 16 when the control device 20 is in place.
  • the control device 20 may contain a plurality of windings 22 each uniquely tuned to the windings of the electrodes 10 , 10 ′, 10 ′′ such that each electrode 10 , 10 ′, 10 ′′ may be uniquely paced.
  • each of the electrodes 10 , 10 ′, 10 ′′ can be provided with filter circuits to pass only desired signals to the pacing electrodes.
  • the control device 20 sends a pulsitile signal to the electrode 10 through the inductive coupling of windings 16 and 22 .
  • the electrode 10 causes pacing contraction of the muscle.
  • the pacing is selected to contract the muscle up to and including tetanic contraction.
  • the muscle is contracted to increase the size of the airway and reduce palatal flutter.
  • the amount of pacing can be tuned to the unique physiology of the patient.
  • the control device need only be used during sleep. It is anticipated that regular use of the control device 20 results in improved tone of the paced muscles reducing or eliminating future need to use the control device 20 .
  • the present device has more effective pacing since muscles are being paced directly by implanted electrodes rather than through less efficient surface stimulation. Further, the present invention contemplates pacing of all muscles defining the airway passage and not just the soft palate.

Abstract

The present disclosure relates to methods and apparatuses for treating snoring by implanting a stimulating electrode into a patient. The electrode is placed in stimulating contact with an airway passage-controlling muscle of the patient. The electrode is energized to contract the muscle and alter the airway passage.

Description

    BACKGROUND
  • 1. Field of the Invention
  • This invention is directed to method and apparatus for treating snoring.
  • 2. Description of the Prior Art
  • Snoring has received increased scientific and academic attention. One publication estimates that up to 20% of the adult population snores habitually. Huang, et al., “Biomechanics of Snoring”, Endeavour, Vol. 19, No. 3, pp. 96-100 (1995). Snoring can be a serious cause of marital discord. In addition, snoring can present a serious health risk to the snorer. In 10% of habitual snorers, collapse of the airway during sleep can lead to obstructive sleep apnea syndrome. Id.
  • Notwithstanding numerous efforts to address snoring, effective treatment of snoring has been elusive. Such treatment may include mouth guards or other appliances worn by the snorer during sleep. However, patients find such appliances uncomfortable and frequently discontinue use (presumably adding to marital stress).
  • Surgical treatments have been employed. One such treatment is uvulopalatopharyngoplasty. In this procedure, so-called laser ablation is used to remove about 2 cm of the trailing edge of the soft palate thereby reducing the soft palate's ability to flutter between the tongue and the pharyngeal wall of the throat. The procedure is frequently effective to abate snoring but is painful and frequently results in undesirable side effects. Namely, removal of the soft palate trailing edge comprises the soft palate's ability to seal off nasal passages during swallowing and speech. In an estimated 25% of uvulopalatopharyngoplasty patients, fluid escapes from the mouth into the nose while drinking. Huang, et al., supra at 99. Uvulopalatopharyngoplasty (UPPP) is also described in Harries, et al., “The Surgical treatment of snoring”, Journal of Laryngology and Otology, pp. 1105-1106 (1996) which describes removal of up to 1.5 cm of the soft palate. Assessment of snoring treatment is discussed in Cole, et al., “Snoring: A review and a Reassessment”, Journal of Otolaryngology, pp. 303-306 (1995).
  • Huang, et al., supra, describe the soft palate and palatal snoring as an oscillating system which responds to airflow over the soft palate. Resulting flutter of the soft palate (rapidly opening and closing air passages) is a dynamic response generating sounds associated with snoring. Huang, et al., propose an alternative to uvulopalatopharyngoplasty. The proposal includes using a surgical laser to create scar tissue on the surface of the soft palate. The scar is to reduce flexibility of the soft palate to reduce palatal flutter. Huang, et al., report initial results of complete or near-complete reduction in snoring and reduced side effects.
  • Surgical procedures such as uvulopalatopharyngoplasty and those proposed by Huang, et al., continue to have problems. The area of surgical treatment (i.e., removal of palatal tissue or scarring of palatal tissue) may be more than is necessary to treat the patient's condition. Surgical lasers are expensive. The proposed procedures are painful with drawn out and uncomfortable healing periods. The procedures have complications and side effects and variable efficacy (e.g., Huang, et al., report promising results in 75% of patients suggesting a full quarter of patients are not effectively treated after painful surgery). The procedures may involve lasting discomfort. For example, scar tissue on the soft palate may present a continuing irritant to the patient. Importantly, the procedures are not reversible in the event they happen to induce adverse side effects not justified by the benefits of the surgery.
  • Electrical stimulation of the soft palate has been suggested to treat snoring and obstructive sleep apnea. See, e.g., Schwartz, et al., “Effects of electrical stimulation to the soft palate on snoring and obstructive sleep apnea”, J. Prosthetic Dentistry, pp. 273-281 (1996). Devices to apply such stimulation are described in U.S. Pat. Nos. 5,284,161 and 5,792,067. Such devices are appliances requiring patient adherence to a regimen of use as well as subjecting the patient to discomfort during sleep. Alternatively, these devices must be used during the day for a period of time causing disruption of daily activity, interference with daily life. This may generally be assumed to cause them to be prone to a significant risk of non-compliance by the wearer. Such devices, though have met with some success in treating disorders such as snoring and Obstructive Sleep Apnea.
  • SUMMARY OF THE INVENTION
  • According to a preferred embodiment of the present invention, a method and apparatus are disclosed for treating snoring of a patient. The invention includes implanting a stimulating electrode into a patient. The electrode is placed in stimulating contact with an airway passage-controlling muscle of the patient. The electrode is energized to contract the muscle and alter the airway passage.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a side sectional view of a portion of a human head showing a soft palate in a relaxed state and in relation in adjacent anatomical features;
  • FIG. 2 is a portion of the view of FIG. 1 showing the soft palate in a flexed state;
  • FIG. 3 is a front view of an interior of the mouth shown in FIG. 1 and showing an area to be ablated according to a first prior art surgical procedure;
  • FIG. 4 is the view of FIG. 3 and showing an area to be scarred according to a second prior art surgical procedure;
  • FIG. 5 is a schematic representation of a spring-mass system model of the soft palate;
  • FIG. 6 is the view of FIG. 1 showing electrodes placed in the muscles of the soft palate, tongue and throat; and
  • FIG. 7 is a schematic representation of a pacing electrode inductively coupled to a control device.
  • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • For ease of understanding the present invention, the dynamics of snoring are explained with reference to FIGS. 1-5. The hard palate HP overlies the tongue T and forms the roof of the mouth M. The hard palate HP includes a bone support B and does not materially deform during breathing. The soft palate SP is soft and is made up of mucous membrane, fibrous and muscle tissue extending rearward from the hard palate HP. A leading end LE of the soft palate SP is anchored to the trailing end of the hard palate HP. A trailing end TE of the soft palate SP is unattached. Since the soft palate SP is not structurally supported by bone or hard cartilage, the soft palate SP droops down from the plane of the hard palate HP in an arcuate geometry of repose.
  • The pharyngeal airway passes air from the mouth M and the nasal passages N into the trachea TR. The portion of the pharyngeal airway defined between opposing surfaces of the upper surface of the soft palate SP and the wall of the throat is the nasopharynx NP.
  • During normal breathing, the soft palate SP is in the relaxed state shown in FIG. 1 with the nasopharynx NP unobstructed and with air free to flow into the trachea TR from both the mouth M and the nostrils N.
  • During swallowing, the soft palate SP flexes and extends (as shown in FIG. 2) to close the nasopharynx NP thereby preventing fluid flow from the mouth M to the nasal passages N. Simultaneously, the epiglottis EP closes the trachea TR so that food and drink pass only into the esophagus ES and not the trachea TR. The soft palate SP is a valve to prevent regurgitation of food into the nose N. The soft palate SP also regulates airflow through the nose N while talking. Since the soft palate SP performs such important functions, prior art techniques for surgically altering the soft palate SP can compromise these functions.
  • The majority of snoring is caused by the soft palate SP flapping back and forth. If breathing is solely through the nose N with the mouth closed, the trailing edge TE of the soft palate SP is sucked into the nasopharyngeal space NP obstructing the airway and subsequently falls opening the airway in a repeating cycle. When the mouth is open, air flows over the upper and lower surfaces of the soft palate SP causing the soft palate SP to flap up and down alternating in obstructing the oral and nasal passageways M, N. The snoring sound is generated by impulses caused by rapid obstruction and opening of airways. Huang, et al., state the airway passage opening and closing occurs 50 times per second during a snore. Huang, et al., utilizing a spring-mass model (FIG. 5) to illustrate oscillation of the soft palate in response to airflow (where the soft palate is the ball B of mass depending by a spring S from a fixed anchor A).
  • Huang, et al., analogize the shortening of the soft palate SP in uvulopalatopharyngoplasty as effectively raising the critical air flow speed at which soft palate flutter will occur. The shaded area SA in FIG. 3 shows the area of the trailing end TE of the soft palate SP to be removed during this procedure. The alternative procedure proposed by Huang, et al., reduces the flexibility of the soft palate SP through surface scarring which is asserted as effecting the critical flow speed. The shaded area SA′ in FIG. 4 shows the area to be scarred by this alternate procedure. In FIG. 4, dashed line L shows the demarcation between the soft and hard palates.
  • The present invention is directed to a method and apparatus for altering the dynamic response of the soft palate by altering airflow past the soft palate. With reference to the spring-mass model (FIG. 5), the soft palate is moved by airflow. Airflow through an orifice varies in response to the orifice size. The present invention alters the size of the air passage through a minimally invasive surgical implant to allow stimulation of airway defining muscles of the oro-pharynx (i.e., mouth and throat).
  • The present invention stimulates muscles of one or more of the soft palate SP, tongue T and back of the throat. In the soft palate SP, these muscles include, but are not limited to, the Levator veli paltini, the dextera, the Palatopharyngeous and the Palatoglossus muscles. At the back of the throat, these muscles include, but are not limited to, the Superior, Middle and Inferior pharyngeal constrictor, the Salpingopharyngeous and the Stylopharyngeous muscles. In the tongue T, these muscles include, but are not limited to, the Genioglossus and Geniohyoid muscles.
  • Stimulating the muscles of the soft palate, tongue and throat is intended to alter the dynamic response of the soft palate to airflow. Namely, stimulation of the soft palate SP causes the soft palate to move away from the tongue T, stimulation of the tongue T causes the tongue T to move away from the soft palate SP, and stimulation of the back of the throat causes the throat to move rearwardly. Alone or in combination, these actions increase the size of the airway thereby decreasing air velocity and the disrupting force which would otherwise cause oscillation of the soft palate SP.
  • Stimulation of the muscles is accomplished by implanted electrodes 10, 10′ and 10″ placed in the airway passage-defining muscles (identified above) of the soft palate SP, tongue T and back of throat (as illustrated in FIG. 6). Implantable muscle stimulating electrodes are well known and may be such as those used in cardiac pacing.
  • The implant 10, 10′, 10″ can be positioned and stimulated in a plurality of ways to alter the shape of the airway, to change the dynamic response of the airway tissues or a combination of both. Unlike the prior art surgical techniques, the electrodes 10, 10′, 10″ that will be described are easy to insert in a small incision resulting in reduced patient discomfort and are not exposed to the interior of the mouth (such as the surface scarring of Huang, et al.) as a patient irritant. Also, as will be described, the degree of dynamic remodeling and stimulation pattern can be fine tuned avoiding the need for excessive anatomical modification and are reversible in the event of adverse consequences.
  • The present invention permits the surgeon to apply stimulation to various muscles until the desired alteration in airway area and tone is achieved so that snoring inducing oscillation is abated at normal airflow. The individual electrodes 10, 10′, 10″ may be placed into the soft palate, tongue or throat muscles through small individual incisions closed by sutures which is much less traumatic than the gross anatomical destruction of uvulopalatopharyngoplasty or the large surface area scarring proposed by Huang, et al.
  • A control device 20 is provided for controlling the electrodes 10, 10′, 10″. The control device 20 is shown as a removable appliance (schematically shown in FIG. 6 with it being appreciated that appliances for placement in the mouth are well known) which fits the form of the hard palate or sub-lingual spaces.
  • The control device 20 is electrically coupled to the electrodes 10, 10′, 10″ through electromagnetic coupling which avoids the need for electrode leads being exposed from the implants 10, 10′, 10″. Specifically, the electrode 10 (shown in FIG. 7 and it being appreciated that electrodes 10′, 10″ are of similar construction) includes a pacing electrode 12 for stimulating muscle in response to a signal through the electrode 10. Leads 14 connect the pacing electrode 12 to an inductive winding 16. In use, the entire electrode 10 (i.e., each of the components of the pacing electrode 12, leads 14 and winding 16) are imbedded in the patient and not exposed.
  • The control device 20 is shown schematically and includes an inductive winding 22 connected to a control circuit 24. Control circuit 24 is only shown schematically. Control circuits for pacing electrodes are well known and widely used in cardiac pacing. In the present invention, preferably none of the components of the control device 20 (i.e., the winding 22 and circuit 24) are implanted. Instead, preferably such components are contained in the removable oral appliance control device 20 although some elements (e.g., a battery may be worn externally by the patient).
  • The control winding 22 is positioned on the control device 20 to be inductively coupled to the electrode winding 16 when the control device 20 is in place. In the event multiple electrodes 10, 10′, 10″ are placed in multiple muscles, the control device 20 may contain a plurality of windings 22 each uniquely tuned to the windings of the electrodes 10, 10′, 10″ such that each electrode 10, 10′, 10″ may be uniquely paced. Also, each of the electrodes 10, 10′, 10″ can be provided with filter circuits to pass only desired signals to the pacing electrodes.
  • The control device 20 sends a pulsitile signal to the electrode 10 through the inductive coupling of windings 16 and 22. In response, the electrode 10 causes pacing contraction of the muscle. Preferably, the pacing is selected to contract the muscle up to and including tetanic contraction.
  • With the present invention, the muscle is contracted to increase the size of the airway and reduce palatal flutter. The amount of pacing can be tuned to the unique physiology of the patient. The control device need only be used during sleep. It is anticipated that regular use of the control device 20 results in improved tone of the paced muscles reducing or eliminating future need to use the control device 20. Unlike the appliances of U.S. Pat. Nos. 5,284,161 and 5,792,067, the present device has more effective pacing since muscles are being paced directly by implanted electrodes rather than through less efficient surface stimulation. Further, the present invention contemplates pacing of all muscles defining the airway passage and not just the soft palate.
  • Having described the invention, alternatives and embodiments may occur to one of skill in the art. It is intended that such modifications and equivalents shall be included within the scope of the following claims.

Claims (54)

1-12. (canceled)
13. A method of treating snoring comprising: a) monitoring the airway passage of a patient during sleep to identify at least one anatomical structure in the airway passage that vibrates during snoring; b) implanting at least one microstimulator in the proximity of the at least one anatomical structure identified in step a); c) energizing the microstimulator to deliver an electrical stimulation to the anatomical structure to cause at least one muscle to contract and reduce the vibrations of the airway passage.
14. The method of claim 13, further including inserting a distal end of a scope such that the distal end is located in an upper airway of the patient and monitoring the airway passage during sleep.
15. The method of claim 13, further including inserting a distal tip of an insertion tool into the anatomical structure, wherein the microstimulator is located in a lumen of the insertion tool, and activating the insertion tool to eject the microstimulator from the insertion tool, and removing the insertion tool from the anatomical structure.
16. The method of claim 13, further comprising delivering an electrical stimulation to the anatomical structure prior to step b), and observing the anatomical structure for decrease in vibration.
17. The method of claim 16, further comprising inserting a distal tip of an insertion tool into an anatomical structure, applying an electrical current to at least the distal tip of the insertion tool, and delivering an electrical current to the anatomical structure.
18. The method of claim 16, further including inserting a distal tip of an insertion tool into the anatomical structure, wherein the microstimulator is located in a lumen of the insertion tool, and energizing the microstimulator located within the lumen of an insertion tool.
19. The method of claim 13, further comprising testing the microstimulator by emitting electrical stimulations at a plurality of intensities, and observing the anatomical structure to determine the intensity which decreases the vibration of the anatomical structure.
20. The method of claim 19, wherein the electrical stimulation is of an intensity from about 8 to about 800 nC.
21. The method of claim 13, further comprising energizing the microstimulator at a selected frequency to deliver an electrical stimulation to the anatomical structure to cause at least one muscle to contract and reduce the vibrations of the airway passage.
22. The method of claim 21, wherein the frequency is about 1 to about 30 pulses per second.
23. The method of claim 21, further comprising providing interruptions of a selected duration and period in the electrical stimulation to permit the at least one muscle to relax.
24. The method of claim 23 wherein the duration of the interruption is from about 0.2 to about 2 seconds and the selected period is from about 5 to about 20 seconds.
25. The method of claim 13, further comprising: a) sensing when snoring is occurring; and b) generating an electrical stimulus from the microstimulator to contract an oropharyngeal muscle, in response to sensing snoring in step a).
26. The method of claim 25, wherein snoring is sensed by detecting mechanical vibrations of at least one anatomical structure.
27. The method of claim 25, wherein snoring is sensed by acoustically detecting sounds generated by vibrating at least one anatomical structure in the airway passages.
28. The method of claim 13, wherein the energizing includes delivering a control signal to a pair of electrodes, wherein the microstimulator includes the pair of electrodes.
29. The method of claim 13, wherein the anatomical structure is selected from the group comprising: the soft palate or the uvula.
30. The method of claim 13, wherein the anatomical structure is a muscle selected from the group comprising: palatoglossus, palatopharyngeal, musculus uvulae, genioglossus, geniohyoid, levator palati or tensor palati.
31. The method of claim 13, wherein the anatomical structure is a branch or terminal of a nerve selected from the group comprising: vagus X, hypoglossal, vagus pharyngeal branch, V3 branch trigeminal nerve.
32. The method of claim 13, further comprising implanting a second microstimulator proximate to at least a second anatomical structure, different than the at least one anatomical structure.
33. The method of claim 32, wherein at least one anatomical structure and a second anatomical structure are muscle pairs selected from the group comprising: geniohyoid and genioglossus; tensor palati and palatoglossus; tensor palati and musculus uvulae.
34. The method of claim 32, wherein at least one of the microstimulators includes a sensor and a telemeter configured to generate a signal indicative of a sensed condition, and at least one of the microstimulators includes a circuitry configured to generate an electrical stimulation pulse.
35. The method of treating snoring comprising: a) implanting a microstimulator within at least one of the soft palate or the uvula; and b) activating the microstimulator to deliver an electrical stimulation to at least one of the soft palate or the uvula to cause at least one muscle to contract.
36. The method of claim 35, wherein the microstimulator includes an electrical circuit configured to generate an electrical stimulus and a pair of electrodes configured to apply the electrical stimulus to the at least one of the soft palate or uvula.
37. The method of claim 35, further comprising transmitting from a controller to the microstimulator power, control signals, or power and control signals.
38. The method of claim 35, further comprising transmitting an acknowledgement signal from the microstimulator to a controller, wherein the acknowledgement signal indicates that the microstimulator has received a control signal from a controller.
39. The method of claim 35, further comprising activating the microstimulator in a temporal pattern to deliver the electrical stimulation to the at least one of the soft palate or the uvula to cause at least one muscle to contract, wherein the temporal pattern includes periods of an absence of electrical stimulation to permit the at least one muscle to cease from contracting.
40. The method of claim 35, further comprising testing the microstimulator by emitting electrical stimulations at a plurality of intensities, and observing at least one of the uvula or soft palate to determine the intensity which decreases the vibration of the uvula or soft palate.
41. The method of claim 40, wherein the electrical stimulation is of an intensity from about 8 to about 800 nC.
42. The method of claim 35, further comprising sensing when snoring is occurring; and electrically stimulating at least one microstimulator implanted within the soft palate or the uvula in response to sensing snoring.
43. The method of claim 42, wherein snoring is sensed by detecting mechanical vibrations of at least on anatomical structure.
44. The method of claim 42, wherein snoring is sensed by acoustically detecting sounds generated by at least one vibrating anatomical structure in the airway passages.
45. The method of claim 35, wherein the microstimulator is implanted in a muscle selected from the group comprising: palatoglossus, palatopharyngeal, or musculus uvulae.
46. The method of claim 35, wherein the microstimulator is implanted proximate to a branch or terminal of the vagus X nerve.
47. The method of claim 35 further comprising implanting a second microstimulator in the proximity of an anatomical structure selected from the group comprising: palatoglossus, palatopharyngeal, musculus uvulae, genioglossus, geniohyoid, levator palate, tensor palati, vagus X, hypoglossal, vagus pharyngeal branch, V3 branch trigeminal nerve.
48. The method of claim 35, further comprising: a) inserting a distal tip of an insertion tool including a microstimulator through the oral mucosa of the soft palate; b) inserting the distal tip of the insertion tool into the uvula; c) activating the insertion tool to deposit the microstimulator from the insertion tool; and d) removing the insertion tool from the uvula.
49. The method of claim 48, further including positioning the microstimulator in or in the proximity of the musculus uvulae.
50. The method of claim 48, further including positioning the microstimulator in the proximity of the terminal branches of the motor axons to the musculus uvulae, wherein the microstimulator includes a cathode and an anode; and positioning the microstimulator cathode in the proximity of the terminal branches of the motor axons to the musculus uvulae.
51. The method of claim 48, further comprising advancing a distal tip of an insertion tool through the oral mucosa to the soft palate to the uvula, wherein the distal tip of the insertion tool includes a microstimulator within a lumen of the distal tip; and testing microstimulator by emitting electrical stimulation from the microstimulator within the lumen of the distal tip; and withdrawing the insertion tool leaving the microstimulator within the uvula.
52. The method of implanting a microstimulator into the genioglossus muscle comprising: a) inserting a distal tip of an insertion tool through the epidermis under the mandible b) passing the distal tip of the insertion tool through the geniohyoid muscle; c) inserting the distal tip of the insertion tool into the genioglossus muscle; d) depositing the microstimulator in the genioglossus muscle; and e) removing the insertion tool from the body.
53. The method of claim 52, further including positioning the microstimulator in the proximity of the endplate zone of the radially oriented sagittal muscle fibers of the genioglossus muscle, wherein the microstimulator includes a cathode and an anode; and positioning the microstimulator cathode in the proximity of the endplate-zone of the radially oriented sagittal muscle fibers of the genioglossus muscle.
54. The method of claim 52, further comprising advancing a distal tip of an insertion tool through the geniohyoid muscle to the genioglossus muscle, wherein the distal tip of the insertion tool includes a microstimulator within a lumen of the distal tip; and testing microstimulator by emitting electrical stimulation from the microstimulator within the lumen of the distal tip; and withdrawing the insertion tool leaving the microstimulator within the genioglossus.
55. The method treating snoring in a patient comprising alternately stimulating at least a first and second muscle in the oropharynx to contract so that an airway passage remain substantially free of vibrating soft tissue during sleep.
56. The method treating snoring in a patient comprising alternately stimulating at least a first and second muscle in the oropharynx to contract so that an airway passage remains substantially free of vibrating soft tissue during sleep, and selecting a pattern of stimulation such that while the first muscle is being contracted the second muscle may have a period of relaxation, and while the second muscle is being contracted, the first muscle may have a period of relaxation.
57. The method of claim 43 wherein the first and second muscles are selected from the group comprising: palatoglossus, palatopharyngeal, musculus uvulae, genioglossus, geniohyoid, levator palati, tensor palati.
58. The method of claim 55, wherein the first and second muscles are selected from the groups of pairs comprising: tensor palati and palatoglossus; tensor palati and musculus uvulae; and geniohyoid and genioglossus.
59. The method of claim 55, further comprising monitoring an airway passage of the patient during sleep to identify at least one anatomical structure in the airway passage that vibrates during snoring.
60. The method of claim 55, further comprising: a) sensing when snoring is occurring; and b) generating an electrical stimulus from the microstimulator to contract an oropharyngeal muscle, in response to sensing snoring in step a).
61. The method of claim 60, wherein snoring is sensed by detecting mechanical vibrations of at least one anatomical structure.
62. The method of claim 60, wherein snoring is sensed by acoustically detecting sounds generated by at least one vibrating anatomical structure in the airway passages.
63. The method of claim 60, further including implanting at least a first microstimulator and a second microstimulator, and wherein the first and second microstimulators are alternately activated to cause the contraction of the at least first and second muscle in the oropharynx
64. The method of claim 63, further comprising alternately applying electrical stimulations of an intensity from about 8 to about 800 nC to stimulate at least the first and second muscle in the oropharynx to contract.
65. The method of claim 55, further comprising applying electrical stimulations for a selected duration to stimulate at least the first muscle in the oropharynx to contract, and interrupting the electrical stimulation for a selected duration at a selected period to permit the first muscle in the oropharynx to relax.
US11/197,054 1999-09-29 2005-08-03 Microstimulator treatment for sleep apnea or snoring Abandoned US20050267547A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/197,054 US20050267547A1 (en) 1999-09-29 2005-08-03 Microstimulator treatment for sleep apnea or snoring

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/409,018 US6636767B1 (en) 1999-09-29 1999-09-29 Implanatable stimulation device for snoring treatment
US10/665,746 US20040073272A1 (en) 1999-09-29 2003-09-19 Implantable stimulation device for snoring treatment
US11/197,054 US20050267547A1 (en) 1999-09-29 2005-08-03 Microstimulator treatment for sleep apnea or snoring

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/665,746 Continuation US20040073272A1 (en) 1999-09-29 2003-09-19 Implantable stimulation device for snoring treatment

Publications (1)

Publication Number Publication Date
US20050267547A1 true US20050267547A1 (en) 2005-12-01

Family

ID=23618725

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/409,018 Expired - Lifetime US6636767B1 (en) 1999-09-29 1999-09-29 Implanatable stimulation device for snoring treatment
US10/665,746 Abandoned US20040073272A1 (en) 1999-09-29 2003-09-19 Implantable stimulation device for snoring treatment
US11/197,054 Abandoned US20050267547A1 (en) 1999-09-29 2005-08-03 Microstimulator treatment for sleep apnea or snoring

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/409,018 Expired - Lifetime US6636767B1 (en) 1999-09-29 1999-09-29 Implanatable stimulation device for snoring treatment
US10/665,746 Abandoned US20040073272A1 (en) 1999-09-29 2003-09-19 Implantable stimulation device for snoring treatment

Country Status (3)

Country Link
US (3) US6636767B1 (en)
AU (1) AU7725700A (en)
WO (1) WO2001023039A1 (en)

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US7809442B2 (en) 2006-10-13 2010-10-05 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8096303B2 (en) 2005-02-08 2012-01-17 Koninklijke Philips Electronics N.V Airway implants and methods and devices for insertion and retrieval
US8371307B2 (en) 2005-02-08 2013-02-12 Koninklijke Philips Electronics N.V. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US8386046B2 (en) 2011-01-28 2013-02-26 Apnex Medical, Inc. Screening devices and methods for obstructive sleep apnea therapy
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US8412338B2 (en) 2008-11-18 2013-04-02 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US8612002B2 (en) 2009-12-23 2013-12-17 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8729129B2 (en) 2004-03-25 2014-05-20 The Feinstein Institute For Medical Research Neural tourniquet
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8855771B2 (en) 2011-01-28 2014-10-07 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US8886339B2 (en) 2009-06-09 2014-11-11 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US8938299B2 (en) 2008-11-19 2015-01-20 Inspire Medical Systems, Inc. System for treating sleep disordered breathing
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9186511B2 (en) 2006-10-13 2015-11-17 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9205262B2 (en) 2011-05-12 2015-12-08 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
WO2016115170A1 (en) * 2015-01-12 2016-07-21 Theodore R. Kucklick Device and method for treatment of sleep apnea
US9486628B2 (en) 2009-03-31 2016-11-08 Inspire Medical Systems, Inc. Percutaneous access for systems and methods of treating sleep apnea
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9643022B2 (en) 2013-06-17 2017-05-09 Nyxoah SA Flexible control housing for disposable patch
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9744354B2 (en) 2008-12-31 2017-08-29 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
US9849289B2 (en) 2009-10-20 2017-12-26 Nyxoah SA Device and method for snoring detection and control
US9855032B2 (en) 2012-07-26 2018-01-02 Nyxoah SA Transcutaneous power conveyance device
US9867733B2 (en) 2013-08-01 2018-01-16 Cook Medical Technologies Llc Tissue adjustment implant
US9888864B2 (en) 2010-03-12 2018-02-13 Inspire Medical Systems, Inc. Method and system for identifying a location for nerve stimulation
US9889299B2 (en) 2008-10-01 2018-02-13 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US9913661B2 (en) 2014-08-04 2018-03-13 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
US9943686B2 (en) 2009-10-20 2018-04-17 Nyxoah SA Method and device for treating sleep apnea based on tongue movement
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US9974563B2 (en) 2014-05-28 2018-05-22 Cook Medical Technologies Llc Medical devices having a releasable member and methods of using the same
US10022263B2 (en) 2011-07-14 2018-07-17 Cook Medical Technologies Llc Sling-based treatment of obstructive sleep apnea
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
US10123900B2 (en) 2013-03-15 2018-11-13 Cook Medical Technologies Llc Devices, kits, and methods for the treatment of obstructive sleep apnea
US10166017B2 (en) 2013-08-05 2019-01-01 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
US20190167984A1 (en) * 2017-12-05 2019-06-06 David Buck Device to induce electrical muscle relaxation for airway management
US10314736B2 (en) 2012-10-16 2019-06-11 Cook Medical Technologies Llc Method and apparatus for treating obstructive sleep apnea (OSA)
US10314501B2 (en) 2016-01-20 2019-06-11 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US10695569B2 (en) 2016-01-20 2020-06-30 Setpoint Medical Corporation Control of vagal stimulation
US10751537B2 (en) 2009-10-20 2020-08-25 Nyxoah SA Arced implant unit for modulation of nerves
US10765862B2 (en) 2017-10-24 2020-09-08 Vanderbilt University Systems and methods for treating sleep disordered breathing
US10814137B2 (en) 2012-07-26 2020-10-27 Nyxoah SA Transcutaneous power conveyance device
US10842653B2 (en) 2007-09-19 2020-11-24 Ability Dynamics, Llc Vacuum system for a prosthetic foot
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11253712B2 (en) 2012-07-26 2022-02-22 Nyxoah SA Sleep disordered breathing treatment apparatus
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11344724B2 (en) 2004-12-27 2022-05-31 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US11357660B2 (en) 2017-06-29 2022-06-14 Cook Medical Technologies, LLC Implantable medical devices for tissue repositioning
US11383083B2 (en) 2014-02-11 2022-07-12 Livanova Usa, Inc. Systems and methods of detecting and treating obstructive sleep apnea
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US11771901B2 (en) 2015-11-17 2023-10-03 Inspire Medical Systems, Inc. Microstimulation sleep disordered breathing (SDB) therapy device
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6431174B1 (en) * 2000-08-10 2002-08-13 Pi Medical, Inc. Method and apparatus to treat conditions of the naso-pharyngeal area
US6502574B2 (en) 1999-09-17 2003-01-07 Pi Medical, Inc. Lateral stiffening snoring treatment
US6636767B1 (en) * 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
ZA200306564B (en) * 2001-02-26 2004-10-15 Optinose As Nasal devices.
US6642334B2 (en) 2001-07-09 2003-11-04 Carlsberg A/S Beaded polyethylene glycol-based resins
US7146981B2 (en) * 2002-02-04 2006-12-12 Restore Medical, Inc. Pharyngeal wall treatment
US7017582B2 (en) * 2002-02-04 2006-03-28 Restore Medical Inc. Stiffening pharyngeal wall treatment
DE10239321B3 (en) * 2002-08-27 2004-04-08 Pari GmbH Spezialisten für effektive Inhalation Aerosol therapy device
US8511315B2 (en) 2002-09-06 2013-08-20 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems in the upper airway
US7188627B2 (en) * 2002-09-06 2007-03-13 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
US8528564B2 (en) * 2002-09-06 2013-09-10 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems affecting both the tongue and the soft palate/uvula in the upper airway
US7360542B2 (en) * 2002-09-06 2008-04-22 Apneon, Inc. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
US20060289014A1 (en) * 2002-09-06 2006-12-28 Apneon, Inc. Devices, systems, and methods using magnetic force systems in or on tissue in an airway
US8590537B2 (en) * 2002-09-06 2013-11-26 Koninklijke Philips N.V. Devices, systems and methods using magnetic force systems in the tongue
US8807137B2 (en) * 2002-09-06 2014-08-19 Koninklijke Philips N.V. Self-anchoring magnetic force implant devices, systems, and methods
US20070256693A1 (en) * 2002-09-06 2007-11-08 Apneon, Inc. Devices, systems, and methods using magnetic force systems in or on soft palate tissue
US8001971B2 (en) * 2002-09-06 2011-08-23 Koninklijke Philips Electronics N.V. Devices, systems, and methods for stabilization or fixation of magnetic force devices used in or on a body
US8522790B2 (en) 2002-09-06 2013-09-03 Koninklijke Philips N.V. Stabilized magnetic force devices, systems and methods
US8020560B2 (en) * 2002-09-06 2011-09-20 Koninklijke Philips Electronics N.V. Devices, systems and methods using magnetic force systems affecting the tongue or hyoid muscles in the upper airway
US7721740B2 (en) * 2002-09-06 2010-05-25 Koninklijke Philips Electronics N.V. Devices, systems, and methods using magnetic force systems in or on tissue
US8047206B2 (en) 2002-09-06 2011-11-01 Koninklijke Philips Electronics N.V. Magnetic devices, systems, and methods placed in or on a tongue
US7441559B2 (en) * 2002-09-06 2008-10-28 Koninklijke Philips Electronics N.V. Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
CA2635955A1 (en) * 2002-10-04 2004-04-22 Pavad Medical, Inc. System and method for preventing closure of passageways
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7277749B2 (en) * 2003-01-15 2007-10-02 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Treatments for snoring using injectable neuromuscular stimulators
US20070270631A1 (en) * 2003-01-22 2007-11-22 Apneon, Inc. Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit
US8146600B2 (en) 2003-07-22 2012-04-03 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7213599B2 (en) * 2003-10-31 2007-05-08 Restore Medical, Inc. Airway implant
US7237554B2 (en) * 2003-10-31 2007-07-03 Restore Medical, Inc. Airway implant
AU2004288711A1 (en) * 2003-11-05 2005-05-26 Pavad Medical, Inc. Electrically activated alteration of body tissue stiffness for breathing disorders
EP2433593B1 (en) * 2003-11-20 2020-07-15 Koninklijke Philips N.V. Devices, systems and methods to fixate tissue within the regions of body, such as the pharyngeal conduit
WO2005079909A1 (en) * 2004-02-20 2005-09-01 Resmed Limited Method and apparatus for detection and treatment of respiratory disorder by implantable device
US10524954B2 (en) 2004-02-26 2020-01-07 Linguaflex, Inc. Methods and devices for treating sleep apnea and snoring
WO2005082452A1 (en) * 2004-02-26 2005-09-09 Ira Sanders A method and device for the treatment of obstructive sleep apnea and snoring
US8074655B2 (en) 2004-02-26 2011-12-13 Linguaflex, Inc. Methods and devices for treating sleep apnea and snoring
US7540699B2 (en) * 2004-04-15 2009-06-02 Stafast Products, Inc. Adjustable threshold fastener with flanges
US8813753B2 (en) * 2004-09-21 2014-08-26 Medtronic Xomed, Inc. Implantable obstructive sleep apnea sensor
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US8578937B2 (en) 2004-09-21 2013-11-12 Medtronic Xomed, Inc. Smart mandibular repositioning system
US7836888B2 (en) * 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
US7322356B2 (en) * 2005-02-24 2008-01-29 Restore Medical, Inc. Combination sleep apnea treatment
US7680538B2 (en) * 2005-03-31 2010-03-16 Case Western Reserve University Method of treating obstructive sleep apnea using electrical nerve stimulation
DE102006001113B3 (en) * 2006-01-09 2007-06-28 Pari GmbH Spezialisten für effektive Inhalation Aerosol therapy device comprises an atomizer, an aerosol generator, a nosepiece for delivering aerosol to one nostril, a device for creating flow resistance in the other nostril, and a connector that imparts pressure fluctuations
CA2641821C (en) * 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US8657172B2 (en) 2006-11-06 2014-02-25 Avery Dennison Corporation Device for dispensing plastic fasteners
EP1980285B1 (en) * 2007-04-11 2009-11-18 PARI GmbH Spezialisten für effektive Inhalation Aerosol therapy device
AU2008311312A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US8167787B2 (en) * 2008-01-03 2012-05-01 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US9439801B2 (en) 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
WO2009140197A1 (en) 2008-05-12 2009-11-19 Revent Medical, Inc. Partially erodable systems for treatment of obstructive sleep apnea
US20100055041A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Nanotracer for in-situ gastric cancer detection
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
US9925086B2 (en) 2008-10-16 2018-03-27 Linguaflex, Inc. Methods and devices for treating sleep apnea
US10806926B2 (en) 2009-10-20 2020-10-20 Man & Science Sa Implantable electrical stimulator
US9415215B2 (en) 2009-10-20 2016-08-16 Nyxoah SA Methods for treatment of sleep apnea
BR112012010986A2 (en) 2009-11-10 2016-04-12 Imthera Medical Inc system to stimulate a hypoglossal nerve to control a patient's tongue position
JP2013521952A (en) 2010-03-19 2013-06-13 レベント メディカル インコーポレイテッド Sleep apnea treatment system and method
EP2547296A4 (en) 2010-03-19 2014-08-06 Revent Medical Inc Systems and methods for treatment of sleep apnea
CA2799435A1 (en) 2010-05-21 2011-11-24 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
EP2598091A4 (en) 2010-07-26 2014-08-20 Revent Medical Inc Systems and methods for treatment of sleep apnea
US8844537B1 (en) 2010-10-13 2014-09-30 Michael T. Abramson System and method for alleviating sleep apnea
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
WO2013023218A1 (en) 2011-08-11 2013-02-14 Inspire Medical Systems, Inc. System for selecting a stimulation protocol based on sensed respiratory effort
US8934992B2 (en) 2011-09-01 2015-01-13 Inspire Medical Systems, Inc. Nerve cuff
WO2013046035A2 (en) 2011-09-30 2013-04-04 Adi Mashiach Systems and methods for determining a sleep disorder based on positioning of the tongue
US10195426B2 (en) 2014-01-07 2019-02-05 Invicta Medical, Inc. Method and apparatus for treating sleep apnea
EP3271008A1 (en) 2015-03-19 2018-01-24 Inspire Medical Systems, Inc. Stimulation for treating sleep disordered breathing
WO2019032890A1 (en) 2017-08-11 2019-02-14 Inspire Medical Systems, Inc. Cuff electrode
US11491324B2 (en) 2019-10-16 2022-11-08 Invicta Medical, Inc. Adjustable devices for treating sleep apnea, and associated systems and methods
JP2023548970A (en) 2020-11-04 2023-11-21 インヴィクタ メディカル インコーポレイテッド Remotely powered implantable electrodes and related systems and methods for treating sleep apnea

Citations (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998209A (en) * 1975-12-16 1976-12-21 Macvaugh Gilbert S Snoring deconditioning system and method
US4637405A (en) * 1983-04-01 1987-01-20 Biosonics, Inc. Apparatus for stimulating salivation
US4830008A (en) * 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea
US4978323A (en) * 1989-08-10 1990-12-18 George Freedman System and method for preventing closure of passageways
US5046512A (en) * 1989-03-10 1991-09-10 Murchie John A Method and apparatus for treatment of snoring
US5052409A (en) * 1989-05-08 1991-10-01 Tepper Harry W Oral appliance for tongue thrust correction
US5133354A (en) * 1990-11-08 1992-07-28 Medtronic, Inc. Method and apparatus for improving muscle tone
US5158080A (en) * 1990-11-08 1992-10-27 Medtronic, Inc. Muscle tone
US5176618A (en) * 1989-08-10 1993-01-05 George Freedman System for preventing closure of passageways
US5178156A (en) * 1989-06-20 1993-01-12 Chest Corporation Apnea preventive stimulating device
US5190053A (en) * 1991-02-28 1993-03-02 Jeffrey A. Meer, Revocable Living Trust Method and apparatus for electrical sublingual stimulation
US5212476A (en) * 1990-09-28 1993-05-18 Maloney Sean R Wireless intraoral controller disposed in oral cavity with electrodes to sense E.M.G. signals produced by contraction of the tongue
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
US5284161A (en) * 1992-11-12 1994-02-08 Karell Manuel L Snopper-the snoring stopper anti-snoring mouth device
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5540733A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for detecting and treating obstructive sleep apnea
US5591216A (en) * 1995-05-19 1997-01-07 Medtronic, Inc. Method for treatment of sleep apnea by electrical stimulation
US5674191A (en) * 1994-05-09 1997-10-07 Somnus Medical Technologies, Inc. Ablation apparatus and system for removal of soft palate tissue
US5792067A (en) * 1995-11-21 1998-08-11 Karell; Manuel L. Apparatus and method for mitigating sleep and other disorders through electromuscular stimulation
US5843021A (en) * 1994-05-09 1998-12-01 Somnus Medical Technologies, Inc. Cell necrosis apparatus
US5897579A (en) * 1994-09-15 1999-04-27 Mount Sinai School Of Medicine Method of relieving airway obstruction in patients with bilateral vocal impairment
US5922006A (en) * 1996-08-12 1999-07-13 Sugerman; Joseph H. Nasal appliance
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US6212435B1 (en) * 1998-11-13 2001-04-03 Respironics, Inc. Intraoral electromuscular stimulation device and method
US6216702B1 (en) * 1994-12-14 2001-04-17 Camtech As Internal registration of gas/air—and other fluid flows in a human body and use of pressure sensors for such registration
US6240316B1 (en) * 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
US20020049479A1 (en) * 2000-10-20 2002-04-25 Pitts Walter C. Method and apparatus for creating afferents to prevent obstructive sleep apnea
US6636767B1 (en) * 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
US6658301B2 (en) * 2000-09-13 2003-12-02 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus for conditioning muscles during sleep
US20040045556A1 (en) * 2002-09-06 2004-03-11 Swan Medical Systems and methods for moving and/or restraining tissue in the upper respiratory system
US6748950B2 (en) * 2001-04-30 2004-06-15 Closure Medical Corporation Compositions and medical procedure to treat snoring
US20040134491A1 (en) * 2002-12-30 2004-07-15 Quiescence Medical Apparatus and methods for treating sleep apnea
US20040153127A1 (en) * 2003-01-15 2004-08-05 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Treatments for snoring using injectable neuromuscular stimulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1553140A1 (en) 1988-06-15 1990-03-30 Пермский государственный медицинский институт Method of electric stimulation of soft palate muscles
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5922066A (en) * 1997-02-24 1999-07-13 Samsung Electronics Co., Ltd. Multifunction data aligner in wide data width processor
US5988171A (en) * 1997-06-26 1999-11-23 Influence Medical Technologies, Ltd. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US6216703B1 (en) * 1998-05-08 2001-04-17 Thermatrx, Inc. Therapeutic prostatic thermotherapy

Patent Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998209A (en) * 1975-12-16 1976-12-21 Macvaugh Gilbert S Snoring deconditioning system and method
US4637405A (en) * 1983-04-01 1987-01-20 Biosonics, Inc. Apparatus for stimulating salivation
US4830008A (en) * 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea
US5046512A (en) * 1989-03-10 1991-09-10 Murchie John A Method and apparatus for treatment of snoring
US5052409A (en) * 1989-05-08 1991-10-01 Tepper Harry W Oral appliance for tongue thrust correction
US5178156A (en) * 1989-06-20 1993-01-12 Chest Corporation Apnea preventive stimulating device
US5176618A (en) * 1989-08-10 1993-01-05 George Freedman System for preventing closure of passageways
US4978323A (en) * 1989-08-10 1990-12-18 George Freedman System and method for preventing closure of passageways
US5212476A (en) * 1990-09-28 1993-05-18 Maloney Sean R Wireless intraoral controller disposed in oral cavity with electrodes to sense E.M.G. signals produced by contraction of the tongue
US5158080A (en) * 1990-11-08 1992-10-27 Medtronic, Inc. Muscle tone
US5133354A (en) * 1990-11-08 1992-07-28 Medtronic, Inc. Method and apparatus for improving muscle tone
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
US5190053A (en) * 1991-02-28 1993-03-02 Jeffrey A. Meer, Revocable Living Trust Method and apparatus for electrical sublingual stimulation
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5718702A (en) * 1992-08-12 1998-02-17 Somnus Medical Technologies, Inc. Uvula, tonsil, adenoid and sinus tissue treatment device and method
US5284161A (en) * 1992-11-12 1994-02-08 Karell Manuel L Snopper-the snoring stopper anti-snoring mouth device
USRE36120E (en) * 1992-11-12 1999-03-02 Karell; Manuel L. Snopper--the snoring stopper anti-snoring mouth device
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5674191A (en) * 1994-05-09 1997-10-07 Somnus Medical Technologies, Inc. Ablation apparatus and system for removal of soft palate tissue
US5843021A (en) * 1994-05-09 1998-12-01 Somnus Medical Technologies, Inc. Cell necrosis apparatus
US5897579A (en) * 1994-09-15 1999-04-27 Mount Sinai School Of Medicine Method of relieving airway obstruction in patients with bilateral vocal impairment
US5540733A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for detecting and treating obstructive sleep apnea
US6216702B1 (en) * 1994-12-14 2001-04-17 Camtech As Internal registration of gas/air—and other fluid flows in a human body and use of pressure sensors for such registration
US5591216A (en) * 1995-05-19 1997-01-07 Medtronic, Inc. Method for treatment of sleep apnea by electrical stimulation
US5792067A (en) * 1995-11-21 1998-08-11 Karell; Manuel L. Apparatus and method for mitigating sleep and other disorders through electromuscular stimulation
US5979456A (en) * 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US5922006A (en) * 1996-08-12 1999-07-13 Sugerman; Joseph H. Nasal appliance
US6345202B2 (en) * 1998-08-14 2002-02-05 Advanced Bionics Corporation Method of treating obstructive sleep apnea using implantable electrodes
US6240316B1 (en) * 1998-08-14 2001-05-29 Advanced Bionics Corporation Implantable microstimulation system for treatment of sleep apnea
US6212435B1 (en) * 1998-11-13 2001-04-03 Respironics, Inc. Intraoral electromuscular stimulation device and method
US6636767B1 (en) * 1999-09-29 2003-10-21 Restore Medical, Inc. Implanatable stimulation device for snoring treatment
US6658301B2 (en) * 2000-09-13 2003-12-02 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Method and apparatus for conditioning muscles during sleep
US20020049479A1 (en) * 2000-10-20 2002-04-25 Pitts Walter C. Method and apparatus for creating afferents to prevent obstructive sleep apnea
US6748950B2 (en) * 2001-04-30 2004-06-15 Closure Medical Corporation Compositions and medical procedure to treat snoring
US20040045556A1 (en) * 2002-09-06 2004-03-11 Swan Medical Systems and methods for moving and/or restraining tissue in the upper respiratory system
US20040134491A1 (en) * 2002-12-30 2004-07-15 Quiescence Medical Apparatus and methods for treating sleep apnea
US20040153127A1 (en) * 2003-01-15 2004-08-05 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Treatments for snoring using injectable neuromuscular stimulators

Cited By (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166395B2 (en) 2000-05-23 2019-01-01 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US10561846B2 (en) 2000-05-23 2020-02-18 The Feinstein Institutes For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US9987492B2 (en) 2000-05-23 2018-06-05 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US8729129B2 (en) 2004-03-25 2014-05-20 The Feinstein Institute For Medical Research Neural tourniquet
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11344724B2 (en) 2004-12-27 2022-05-31 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US8096303B2 (en) 2005-02-08 2012-01-17 Koninklijke Philips Electronics N.V Airway implants and methods and devices for insertion and retrieval
US8371307B2 (en) 2005-02-08 2013-02-12 Koninklijke Philips Electronics N.V. Methods and devices for the treatment of airway obstruction, sleep apnea and snoring
US8757163B2 (en) 2005-02-08 2014-06-24 Koninklijke Philips N.V. Airway implants and methods and devices for insertion and retrieval
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
US8718783B2 (en) 2006-10-13 2014-05-06 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
USRE48025E1 (en) 2006-10-13 2020-06-02 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8626304B2 (en) 2006-10-13 2014-01-07 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US10632308B2 (en) 2006-10-13 2020-04-28 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8744589B2 (en) 2006-10-13 2014-06-03 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8498712B2 (en) 2006-10-13 2013-07-30 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US11517746B2 (en) 2006-10-13 2022-12-06 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US11471685B2 (en) 2006-10-13 2022-10-18 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
USRE48024E1 (en) 2006-10-13 2020-06-02 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8639354B2 (en) 2006-10-13 2014-01-28 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8428727B2 (en) 2006-10-13 2013-04-23 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9186511B2 (en) 2006-10-13 2015-11-17 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8417343B2 (en) 2006-10-13 2013-04-09 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US7809442B2 (en) 2006-10-13 2010-10-05 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8311645B2 (en) 2006-10-13 2012-11-13 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US10842653B2 (en) 2007-09-19 2020-11-24 Ability Dynamics, Llc Vacuum system for a prosthetic foot
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US11806537B2 (en) 2008-10-01 2023-11-07 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US11083899B2 (en) 2008-10-01 2021-08-10 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US9889299B2 (en) 2008-10-01 2018-02-13 Inspire Medical Systems, Inc. Transvenous method of treating sleep apnea
US8412338B2 (en) 2008-11-18 2013-04-02 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US8938299B2 (en) 2008-11-19 2015-01-20 Inspire Medical Systems, Inc. System for treating sleep disordered breathing
US10888267B2 (en) 2008-11-19 2021-01-12 Inspire Medical Systems, Inc. Method of treating sleep disordered breathing
US10737094B2 (en) 2008-12-31 2020-08-11 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US10105538B2 (en) 2008-12-31 2018-10-23 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9744354B2 (en) 2008-12-31 2017-08-29 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US10632306B2 (en) 2008-12-31 2020-04-28 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US11400287B2 (en) 2008-12-31 2022-08-02 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US10543366B2 (en) 2009-03-31 2020-01-28 Inspire Medical Systems, Inc. Percutaneous access for systems and methods of treating sleep-related disordered breathing
US9486628B2 (en) 2009-03-31 2016-11-08 Inspire Medical Systems, Inc. Percutaneous access for systems and methods of treating sleep apnea
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9849286B2 (en) 2009-05-01 2017-12-26 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US10220203B2 (en) 2009-06-09 2019-03-05 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US10716936B2 (en) 2009-06-09 2020-07-21 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US9174041B2 (en) 2009-06-09 2015-11-03 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US8886339B2 (en) 2009-06-09 2014-11-11 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US9700716B2 (en) 2009-06-09 2017-07-11 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
US10751537B2 (en) 2009-10-20 2020-08-25 Nyxoah SA Arced implant unit for modulation of nerves
US9950166B2 (en) 2009-10-20 2018-04-24 Nyxoah SA Acred implant unit for modulation of nerves
US9943686B2 (en) 2009-10-20 2018-04-17 Nyxoah SA Method and device for treating sleep apnea based on tongue movement
US10716940B2 (en) 2009-10-20 2020-07-21 Nyxoah SA Implant unit for modulation of small diameter nerves
US9849289B2 (en) 2009-10-20 2017-12-26 Nyxoah SA Device and method for snoring detection and control
US11857791B2 (en) 2009-10-20 2024-01-02 Nyxoah SA Arced implant unit for modulation of nerves
US10898717B2 (en) 2009-10-20 2021-01-26 Nyxoah SA Device and method for snoring detection and control
US11273307B2 (en) 2009-10-20 2022-03-15 Nyxoah SA Method and device for treating sleep apnea
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US11110287B2 (en) 2009-12-23 2021-09-07 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8855767B2 (en) 2009-12-23 2014-10-07 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US9993651B2 (en) 2009-12-23 2018-06-12 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US9162064B2 (en) 2009-12-23 2015-10-20 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8612002B2 (en) 2009-12-23 2013-12-17 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US10384068B2 (en) 2009-12-23 2019-08-20 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US9888864B2 (en) 2010-03-12 2018-02-13 Inspire Medical Systems, Inc. Method and system for identifying a location for nerve stimulation
US11304648B2 (en) 2010-03-12 2022-04-19 Inspire Medical Systems, Inc. Method and system for identifying a location for nerve stimulation
US9113838B2 (en) 2011-01-28 2015-08-25 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US9913982B2 (en) 2011-01-28 2018-03-13 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8386046B2 (en) 2011-01-28 2013-02-26 Apnex Medical, Inc. Screening devices and methods for obstructive sleep apnea therapy
US8855771B2 (en) 2011-01-28 2014-10-07 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US11529514B2 (en) 2011-01-28 2022-12-20 Livanova Usa, Inc. Obstructive sleep apnea treatment devices, systems and methods
US9555247B2 (en) 2011-01-28 2017-01-31 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US10231645B2 (en) 2011-01-28 2019-03-19 Livanova Usa, Inc. Screening devices and methods for obstructive sleep apnea therapy
US11000208B2 (en) 2011-01-28 2021-05-11 Livanova Usa, Inc. Screening devices and methods for obstructive sleep apnea therapy
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9757564B2 (en) 2011-05-12 2017-09-12 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US9205262B2 (en) 2011-05-12 2015-12-08 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US10022263B2 (en) 2011-07-14 2018-07-17 Cook Medical Technologies Llc Sling-based treatment of obstructive sleep apnea
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
US10052484B2 (en) 2011-10-03 2018-08-21 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US10864375B2 (en) 2011-10-03 2020-12-15 Livanova Usa, Inc. Devices and methods for sleep apnea treatment
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US10449358B2 (en) 2012-03-26 2019-10-22 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
US11730469B2 (en) 2012-07-26 2023-08-22 Nyxoah SA Implant unit delivery tool
US11253712B2 (en) 2012-07-26 2022-02-22 Nyxoah SA Sleep disordered breathing treatment apparatus
US9855032B2 (en) 2012-07-26 2018-01-02 Nyxoah SA Transcutaneous power conveyance device
US10814137B2 (en) 2012-07-26 2020-10-27 Nyxoah SA Transcutaneous power conveyance device
US10716560B2 (en) 2012-07-26 2020-07-21 Nyxoah SA Implant unit delivery tool
US10918376B2 (en) 2012-07-26 2021-02-16 Nyxoah SA Therapy protocol activation triggered based on initial coupling
US10314736B2 (en) 2012-10-16 2019-06-11 Cook Medical Technologies Llc Method and apparatus for treating obstructive sleep apnea (OSA)
US10123900B2 (en) 2013-03-15 2018-11-13 Cook Medical Technologies Llc Devices, kits, and methods for the treatment of obstructive sleep apnea
US9643022B2 (en) 2013-06-17 2017-05-09 Nyxoah SA Flexible control housing for disposable patch
US11642534B2 (en) 2013-06-17 2023-05-09 Nyxoah SA Programmable external control unit
US10512782B2 (en) 2013-06-17 2019-12-24 Nyxoah SA Remote monitoring and updating of a medical device control unit
US11298549B2 (en) 2013-06-17 2022-04-12 Nyxoah SA Control housing for disposable patch
US11744726B2 (en) 2013-08-01 2023-09-05 Cook Medical Technologies Llc Tissue adjustment implant
US9867733B2 (en) 2013-08-01 2018-01-16 Cook Medical Technologies Llc Tissue adjustment implant
US10799388B2 (en) 2013-08-01 2020-10-13 Cook Medical Technologies Llc Tissue adjustment implant
US10166017B2 (en) 2013-08-05 2019-01-01 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
US9956384B2 (en) 2014-01-24 2018-05-01 Cook Medical Technologies Llc Articulating balloon catheter and method for using the same
US11383083B2 (en) 2014-02-11 2022-07-12 Livanova Usa, Inc. Systems and methods of detecting and treating obstructive sleep apnea
US9974563B2 (en) 2014-05-28 2018-05-22 Cook Medical Technologies Llc Medical devices having a releasable member and methods of using the same
US10898224B2 (en) 2014-05-28 2021-01-26 Cook Medical Technologies Llc Medical devices having a releasable member and methods of using the same
US9913661B2 (en) 2014-08-04 2018-03-13 Cook Medical Technologies Llc Medical devices having a releasable tubular member and methods of using the same
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016115170A1 (en) * 2015-01-12 2016-07-21 Theodore R. Kucklick Device and method for treatment of sleep apnea
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US11771901B2 (en) 2015-11-17 2023-10-03 Inspire Medical Systems, Inc. Microstimulation sleep disordered breathing (SDB) therapy device
US11278718B2 (en) 2016-01-13 2022-03-22 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
US11547852B2 (en) 2016-01-20 2023-01-10 Setpoint Medical Corporation Control of vagal stimulation
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10314501B2 (en) 2016-01-20 2019-06-11 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US10695569B2 (en) 2016-01-20 2020-06-30 Setpoint Medical Corporation Control of vagal stimulation
US11383091B2 (en) 2016-01-25 2022-07-12 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11357660B2 (en) 2017-06-29 2022-06-14 Cook Medical Technologies, LLC Implantable medical devices for tissue repositioning
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11890471B2 (en) 2017-08-14 2024-02-06 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US10765862B2 (en) 2017-10-24 2020-09-08 Vanderbilt University Systems and methods for treating sleep disordered breathing
US11672979B2 (en) * 2017-12-05 2023-06-13 David Buck Device to induce electrical muscle relaxation for airway management
US20190167984A1 (en) * 2017-12-05 2019-06-06 David Buck Device to induce electrical muscle relaxation for airway management
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11857788B2 (en) 2018-09-25 2024-01-02 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11938324B2 (en) 2020-05-21 2024-03-26 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Also Published As

Publication number Publication date
US20040073272A1 (en) 2004-04-15
WO2001023039A1 (en) 2001-04-05
US6636767B1 (en) 2003-10-21
AU7725700A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
US20050267547A1 (en) Microstimulator treatment for sleep apnea or snoring
US7680538B2 (en) Method of treating obstructive sleep apnea using electrical nerve stimulation
US7277749B2 (en) Treatments for snoring using injectable neuromuscular stimulators
US20070173893A1 (en) Method and apparatus for preventing obstructive sleep apnea
ES2702906T3 (en) System for treating obstructive sleep apnea using a neuromuscular stimulator
US20020049479A1 (en) Method and apparatus for creating afferents to prevent obstructive sleep apnea
JP4808909B2 (en) Method and apparatus for treating symptoms in the nasopharyngeal region
JP6129183B2 (en) Modulator device configured for embedding
US6523543B2 (en) Permanent snoring implant
JP4353642B2 (en) Inner ear vestibular stimulator
US7697990B2 (en) Method and apparatus for detection and treatment of respiratory disorder by implantable device
US20080021506A1 (en) Method and device for the electrical treatment of sleep apnea and snoring
AU2005286641A1 (en) Airway implant and methods of making and using
WO2010006218A2 (en) Sleep apnea device and method
WO2023023494A1 (en) Corrective sleep apnea device

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION